Klinički bolnički centar Zagreb (University Hospital Center Zagreb)
- Address
- lock Available on a paid plan
University Hospital Center Zagreb - Neurological Research
Klinički bolnički centar Zagreb (University Hospital Center Zagreb) is a leading medical institution conducting advanced clinical research in neurological disorders. The center demonstrates specialized expertise in epilepsy treatment and the evaluation of novel therapeutic interventions for patients with difficult-to-treat neurological conditions.
- Refractory focal onset epilepsy investigation and adjunctive therapy development
- Evaluation of innovative antiepileptic medications for seizure management
- Clinical efficacy studies focused on seizure reduction in treatment-resistant patients
The center is actively involved in international multi-center trials examining new pharmacological approaches for patients who have not responded adequately to conventional therapies. Their research particularly focuses on refractory epilepsy, aiming to identify safe and effective treatment options that can significantly reduce seizure frequency and improve quality of life for individuals living with treatment-resistant seizure disorders.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 4 of 13 therapeutic areas and 15 of 120 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 118 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 22 by active trials.
- 1Biohaven Therapeutics Ltd.2active
lock +21 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Amgen Inc.4trials
lock +12 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 60 other sites in Croatia
Therapeutic Area Benchmark — Croatia
Select a therapeutic area to compare against other sites in Croatia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Croatia
Market Share
Country: Croatia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Klinički bolnički centar Zagreb (University Hospital Center Zagreb)
lock Showing 1 of 54 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Comparative Study of Somapacitan and Somatropin in Pediatric Patients with Short Stature Due to SGA, Turner Syndrome, Noonan Syndrome, or Idiopathic Short Stature | Novo Nordisk A/S | Phase III | Not Recruiting | Aug 2022 | — |
IMP list
lock Showing 1 of 120 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Pembrolizumab | 9 | Unknown | 2021-03-17 | 2025-04-18 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.